This site is intended for UK Healthcare Professionals only

UK/FLY/2023/2543 V3 | October 2024

Prescribing information and adverse event reporting statement can be found in the footer

This site is intended for UK Healthcare Professionals only

UK/FLY/2023/2543 V3 | October 2024

Prescribing information and adverse event reporting statement can be found in the footer

Can children swallow tablets? Outcome data from a feasibility study to assess the acceptability of different-sized placebo tablets in children

This event took place on Wednesday 23 November 2022
Your certificate will be available in your account once you have watched the on-demand video.

Agenda

Can children swallow tablets? Outcome data from a feasibility study to assess the acceptability of different-sized placebo tablets in children,Ms Gabrielle Seddon, Paediatric Medicines Research Unit Coordinator, Alder Hey Children’s NHS Foundation Trust. Dr Alice McCloskey, Senior Lecturer- Clinical Pharmacy and Therapeutics, Liverpool John Moores University.
Ms Gabrielle Seddon
Ms Gabrielle Seddon
Paediatric Medicines Research Unit Research Coordinator, Alder Hey Children’s NHS Foundation Trust.

Gaby is the research co-ordinator for the Paediatric Medicines Research Unit (PMRU) at Alder Hey Children’s NHS Foundation Trust. The unit’s research themes are drug safety, formulations and medicines optimisation. Gaby is a registered children’s nurse since 2006 working in neurology /neurosurgery. She became a research nurse in 2009 before moving into the role of PMRU research co-ordinator in 2019, supporting research design, development, delivery and governance. Her research interests include acceptability of medicines in children and young people.

Dr Alice McCloskey
Dr Alice McCloskey
Senior Lecturer- Clinical Pharmacy and Therapeutics, Liverpool John Moores University.

Dr McCloskey is a registered pharmacist of the GPhC and PSNI with a range of experience working across the three main sectors of pharmacy- clinical practice, academia and industry. Upon successful completion of her pre-registration training Dr McCloskey returned to Queen's University Belfast and completed a PhD in pharmaceutics where she developed 'Self-assembled Peptide Nanomaterials for the Prevention of Biomaterial Infection'. This was followed by an industry-academia collaborative post-doc between the Royal College of Surgeons in Ireland (RCSI, Dublin) and the Galway-based nebuliser company Aerogen, a global leader in aerosol delivery. This work was also linked with a national patient focused medical device research centre, CURAM based at The National University of Ireland, Galway. Dr McCloskey is a member of the Royal Pharmaceutical Society and Fellow of HEA (Higher Education Academy). Links are maintained with clinical pharmacy through regular days in practice both in hospital and community settings.

What will the webinar cover?

Key learning objectives

  • To investigate the acceptability of swallowing tablets in children
  • To report findings from CAT and CAT3D feasibility studies
  • To examine novel approaches and techniques to aid pill swallowing